212 related articles for article (PubMed ID: 37795079)
1. Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists.
Fromm G; de Silva S; Schreiber TH
Front Immunol; 2023; 14():1236332. PubMed ID: 37795079
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas.
Gruss HJ; Dower SK
Blood; 1995 Jun; 85(12):3378-404. PubMed ID: 7780126
[TBL] [Abstract][Full Text] [Related]
3. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
Gruss HJ; Duyster J; Herrmann F
Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
[TBL] [Abstract][Full Text] [Related]
4. A family of ligands for the TNF receptor superfamily.
Cosman D
Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
[TBL] [Abstract][Full Text] [Related]
5. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
6. The TNF-TNFR Family of Co-signal Molecules.
So T; Ishii N
Adv Exp Med Biol; 2019; 1189():53-84. PubMed ID: 31758531
[TBL] [Abstract][Full Text] [Related]
7. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB.
Arch RH; Thompson CB
Mol Cell Biol; 1998 Jan; 18(1):558-65. PubMed ID: 9418902
[TBL] [Abstract][Full Text] [Related]
8. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
[TBL] [Abstract][Full Text] [Related]
9. Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes.
Nagai H; Azuma M; Sato A; Shibui N; Ogawara S; Tsutsui Y; Suzuki A; Wakaizumi T; Ito A; Matsuyama S; Morita M; Hikosaka Kuniishi M; Ishii N; So T
Cells; 2023 Jun; 12(12):. PubMed ID: 37371066
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations.
Su Z; Wu Y
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150842
[TBL] [Abstract][Full Text] [Related]
11. Concepts for agonistic targeting of CD40 in immuno-oncology.
Richards DM; Sefrin JP; Gieffers C; Hill O; Merz C
Hum Vaccin Immunother; 2020; 16(2):377-387. PubMed ID: 31403344
[TBL] [Abstract][Full Text] [Related]
12. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
[TBL] [Abstract][Full Text] [Related]
13. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily.
Gruss HJ
Int J Clin Lab Res; 1996; 26(3):143-59. PubMed ID: 8905447
[TBL] [Abstract][Full Text] [Related]
14. TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity.
Yu X; James S; Felce JH; Kellermayer B; Johnston DA; Chan HTC; Penfold CA; Kim J; Inzhelevskaya T; Mockridge CI; Watanabe Y; Crispin M; French RR; Duriez PJ; Douglas LR; Glennie MJ; Cragg MS
Commun Biol; 2021 Jun; 4(1):772. PubMed ID: 34162985
[TBL] [Abstract][Full Text] [Related]
15. The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.
Wortzman ME; Clouthier DL; McPherson AJ; Lin GH; Watts TH
Immunol Rev; 2013 Sep; 255(1):125-48. PubMed ID: 23947352
[TBL] [Abstract][Full Text] [Related]
16. Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein.
Birkeland ML; Copeland NG; Gilbert DJ; Jenkins NA; Barclay AN
Eur J Immunol; 1995 Apr; 25(4):926-30. PubMed ID: 7737295
[TBL] [Abstract][Full Text] [Related]
17. Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.
Chan FK
Cytokine; 2007 Feb; 37(2):101-7. PubMed ID: 17449269
[TBL] [Abstract][Full Text] [Related]
18. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.
Munroe ME; Bishop GA
J Biol Chem; 2004 Dec; 279(51):53222-31. PubMed ID: 15485859
[TBL] [Abstract][Full Text] [Related]
19. Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.
Jhajj HS; Schardt JS; Khalasawi N; Yao EL; Lwo TS; Kwon NY; O'Meara RL; Desai AA; Tessier PM
Cell Chem Biol; 2024 May; 31(5):944-954.e5. PubMed ID: 38653243
[TBL] [Abstract][Full Text] [Related]
20. Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily.
Jhajj HS; Schardt JS; Khalasawi N; Yao EL; Lwo TS; Kwon NY; O'Meara RL; Desai AA; Tessier PM
bioRxiv; 2023 Dec; ():. PubMed ID: 38168220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
